1346 related articles for article (PubMed ID: 24219905)
1. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
5. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells.
Mohammadpour H; Pourfathollah AA; Zarif MN; Tahoori MT
Int Immunopharmacol; 2015 Oct; 28(2):1009-17. PubMed ID: 26303769
[TBL] [Abstract][Full Text] [Related]
6. The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.
Gray A; Marrero-Berrios I; Weinberg J; Manchikalapati D; SchianodiCola J; Schloss RS; Yarmush J
Int Immunopharmacol; 2016 Apr; 33():48-54. PubMed ID: 26854576
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of soluble factors secreted by feline adipose tissue-derived mesenchymal stem cells.
Chae HK; Song WJ; Ahn JO; Li Q; Lee BY; Kweon K; Park SC; Youn HY
Vet Immunol Immunopathol; 2017 Sep; 191():22-29. PubMed ID: 28895862
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
9. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
Hegyi B; Kudlik G; Monostori E; Uher F
Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
[TBL] [Abstract][Full Text] [Related]
10. Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.
Gray A; Maguire T; Schloss R; Yarmush ML
Biotechnol Prog; 2015; 31(4):1058-70. PubMed ID: 25958832
[TBL] [Abstract][Full Text] [Related]
11. Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.
Kang JW; Kang KS; Koo HC; Park JR; Choi EW; Park YH
Stem Cells Dev; 2008 Aug; 17(4):681-93. PubMed ID: 18717642
[TBL] [Abstract][Full Text] [Related]
12. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
Stubbendorff M; Deuse T; Hua X; Phan TT; Bieback K; Atkinson K; Eiermann TH; Velden J; Schröder C; Reichenspurner H; Robbins RC; Volk HD; Schrepfer S
Stem Cells Dev; 2013 Oct; 22(19):2619-29. PubMed ID: 23711207
[TBL] [Abstract][Full Text] [Related]
13. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
14. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.
Hemeda H; Jakob M; Ludwig AK; Giebel B; Lang S; Brandau S
Stem Cells Dev; 2010 May; 19(5):693-706. PubMed ID: 20067407
[TBL] [Abstract][Full Text] [Related]
16. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
[TBL] [Abstract][Full Text] [Related]
17. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis.
Hsu WT; Lin CH; Chiang BL; Jui HY; Wu KK; Lee CM
J Immunol; 2013 Mar; 190(5):2372-80. PubMed ID: 23359497
[TBL] [Abstract][Full Text] [Related]
19. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
20. Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions.
Ylostalo JH; Bazhanov N; Mohammadipoor A; Bartosh TJ
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
